700-84-5 Usage
Description
5-Fluoro-1-indanone is an organic compound that serves as a key intermediate in the synthesis of various pharmaceuticals and organic compounds.
Uses
Used in Pharmaceutical Industry:
5-Fluoro-1-indanone is used as a precursor for the synthesis of thiosemicarbazones derived from 1-indanones. These thiosemicarbazones have potential applications as antimicrobial, antitubercular, and anticancer agents due to their ability to inhibit the growth of various microorganisms and cancer cells.
Used in Organic Synthesis:
5-Fluoro-1-indanone is also used in the synthesis of 6-fluoro-1,2,3,4-tetrahydroquinoline hydrochloride, which is an important intermediate in the preparation of various organic compounds and pharmaceuticals. The presence of the fluorine atom in the molecule allows for the development of new compounds with improved properties and potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 700-84-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 7,0 and 0 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 700-84:
(5*7)+(4*0)+(3*0)+(2*8)+(1*4)=55
55 % 10 = 5
So 700-84-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H6F4O3/c10-8(11)9(12,13)16-6-3-1-2-5(4-6)7(14)15/h1-4,8H,(H,14,15)
700-84-5Relevant articles and documents
Development of a Flow Photochemical Aerobic Oxidation of Benzylic C-H Bonds
Lesieur, Mathieu,Genicot, Christophe,Pasau, Patrick
supporting information, p. 1987 - 1990 (2018/04/16)
A continuous mesofluidic process has been developed for benzylic C-H oxidation with moderate to good yields using a photocatalyst (riboflavin tetraacetate, RFT) activated by a UV lamp and an iron additive [Fe(ClO4)2] via incorporation of singlet oxygen (1O2) for the direct formation of oxidized C=O or CH-OH compounds.
17a-HYDROXYLASE/C17,20-LYASE INHIBITORS
-
, (2014/03/21)
The present invention provides compounds of Formula (I), or a pharmaceutically acceptable salt thereof, where R1, R2, R3, R4, R5, R6, A and n are as defined herein. A deuteriated derivative of the compound of Formula (I) is also provided.
17α-HYDROXYLASE/C17,20-LYASE INHIBITORS
-
, (2012/04/04)
The present invention provides compounds of Formula (I), or a pharmaceutically acceptable salt thereof, where R1, R2, R3, R4, R5, R6, A and n are as defined herein. A deuteriated derivative of the compound of Formula (I) is also provided.